Exagen Inc Stock Alpha and Beta Analysis
| XGN Stock | USD 3.84 0.10 2.54% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Exagen Inc. It also helps investors analyze the systematic and unsystematic risks associated with investing in Exagen over a specified time horizon. Remember, high Exagen's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Exagen's market risk premium analysis include:
Beta 1.04 | Alpha 0.37 | Risk 5.28 | Sharpe Ratio 0.11 | Expected Return 0.58 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Exagen |
Exagen Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Exagen market risk premium is the additional return an investor will receive from holding Exagen long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Exagen. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Exagen's performance over market.| α | 0.37 | β | 1.04 |
Exagen expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Exagen's Buy-and-hold return. Our buy-and-hold chart shows how Exagen performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Exagen Market Price Analysis
Market price analysis indicators help investors to evaluate how Exagen stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Exagen shares will generate the highest return on investment. By understating and applying Exagen stock market price indicators, traders can identify Exagen position entry and exit signals to maximize returns.
Exagen Return and Market Media
The median price of Exagen for the period between Sat, Aug 31, 2024 and Fri, Nov 29, 2024 is 2.9 with a coefficient of variation of 13.18. The daily time series for the period is distributed with a sample standard deviation of 0.39, arithmetic mean of 2.97, and mean deviation of 0.26. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Improved Revenues Required Before Exagen Inc. Stocks 40 percent Jump Looks Justified | 09/06/2024 |
2 | Exagen Inc. Short Interest Up 20.9 percent in September | 09/30/2024 |
3 | Acquisition by Birk Brian of 9000 shares of Exagen subject to Rule 16b-3 | 10/25/2024 |
4 | Exagen Inc. Reports Q3 Loss, Misses Revenue Estimates | 11/12/2024 |
5 | Exagen Inc. Q3 2024 Earnings Call Transcript | 11/13/2024 |
6 | Exagen Releases Earnings Results, Beats Expectations By 0.02 EPS | 11/14/2024 |
7 | Acquisition by Jeffrey Black of 22298 shares of Exagen at 2.98 subject to Rule 16b-3 | 11/15/2024 |
8 | Disposition of 200000 shares by Nmsic Co-investment Fund, L.p. of Exagen at 3.3002 subject to Rule 16b-3 | 11/20/2024 |
9 | Exagen CEO, President Director Acquires 7.7 percent More Stock | 11/21/2024 |
About Exagen Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Exagen or other stocks. Alpha measures the amount that position in Exagen Inc has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 (projected) | Dividend Yield | 0.019 | 0.0169 | Price To Sales Ratio | 0.67 | 0.64 |
Exagen Upcoming Company Events
As portrayed in its financial statements, the presentation of Exagen's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Exagen's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Exagen's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Exagen. Please utilize our Beneish M Score to check the likelihood of Exagen's management manipulating its earnings.
| 18th of March 2024 Upcoming Quarterly Report | View | |
| 20th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 18th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Exagen
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Exagen Backtesting, Exagen Valuation, Exagen Correlation, Exagen Hype Analysis, Exagen Volatility, Exagen History and analyze Exagen Performance. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Exagen technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.